image
Gain Therapeutics, Inc. GANX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.92
-5.28 %
$ 57.5 M
Market Cap
-2.27
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
10.31%
Net Income Estimate
34.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Gain Therapeutics, Inc.
image
GANX has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart GANX

image
$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.0202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart GANX

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart GANX

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)($40.0m)($40.0m)202120212022202220232023202420242025202520262026202720272028202820292029